Somatic Mutations and Their Contribution to Bone Marrow Failure and Inflammation
Explore somatic mutations' role in bone marrow failure and inflammation. Gain insights from David Beck's keynote on cancer genomics and its impact on patient diagnosis and treatment.
TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Explore TP53 alterations in myelodysplastic neoplasms and acute myeloid leukemia, gaining insights from expert Joseph Khoury at the CGC 2023 Annual Meeting.
Incorporating Genomic Information in the Treatment of MDS
Explore genomic information's role in treating Myelodysplastic Syndrome (MDS). Gain insights into cutting-edge approaches for accurate diagnosis and personalized therapy in cancer genomics.
WHO/IARC Overview and CGC Collaboration
Explore WHO/IARC's collaboration with CGC, focusing on best practices in clinical cancer genomics and accurate diagnosis for targeted therapy.
ISCN 2024 Update: Preview of New Genomic Mapping Nomenclature
Explore updates to ISCN 2024 and preview new genomic mapping nomenclature. Gain insights into evolving standards for clinical cancer genomics and their impact on patient care.
Cytogenetics in the Era of Genomics - Invited Speaker Presentation
Explore the continued relevance of cytogenetics in modern genomics, highlighting its crucial role in cancer diagnosis and treatment strategies.
Real World Classification of Variants in Cancer Using ClinGen/CGC/VICC Oncogenicity Recommendations
Explore standardized classification of oncogenic somatic variants in cancer, improving consistency through validated SOP and real-world case demonstrations.
NPM1 Mutation in Myeloid Malignancies - Advancing Precision Medicine
Explore NPM1 mutations in myeloid malignancies and their impact on precision medicine through molecular testing. Gain insights from expert Robert Hasserjian on advancing cancer diagnostics and treatment.
Cancer Genomics Consortium 2023 Webinar Series - CGC 2022 Annual Meeting Poster Winners
Explore cutting-edge cancer genomics research, focusing on childhood brain tumors and ovarian cancer. Gain insights into copy number alterations, single-cell RNA sequencing, and their impact on patient outcomes.
Next-Generation Curating: When Pathology Meets Bioinformatics
Explore the intersection of pathology and bioinformatics in next-generation curating for cancer genomics. Gain insights into best practices and advancements in clinical cancer genomic testing.
Genetic Ancestry, Somatic Alteration and Outcome in Cancer Genomics - Invited Presentation
Explore the relationship between genetic ancestry, somatic alterations, and cancer outcomes in this insightful presentation by Jian Carrot-Zhang at the 2022 CGC Annual Meeting.
CGC 2022 Annual Meeting Poster Winners - January 2023 Webinar
Explore cutting-edge cancer genomics research with presentations on cell-type-specific breast genotyping and standardized assessment of NTRK fusions.
Long Molecule Footprints of Complex Cancer Genome Structure - Invited Presentation
Explore complex cancer genome structures through long molecule footprints. Gain insights into advanced genomic analysis techniques for accurate cancer diagnosis and personalized treatment.
Beyond CNVs: Leveraging SNP Arrays in Cancer
Explore leveraging SNP arrays in cancer genomics beyond CNVs, focusing on mosaic gains/losses, HRD scores, and noninformative SNPs for improved diagnosis and treatment.
Translation Studies in Arboviral Pathogens
Explore chikungunya arthritis and dengue vascular permeability studies, focusing on translational science in arboviral pathogen research.
NGS in the Clinical Laboratory - Experiences of the Holycross Cancer Center with One-Day NGS
Explore clinical NGS implementation at Holycross Cancer Center, focusing on challenges, solutions, and future directions in molecular diagnostics for cancer care.
Utilization of the Genexus Turnkey NGS Platform for Molecular Profiling of NSCLC Samples
Explore molecular profiling of NSCLC samples using the Genexus turnkey NGS platform with Dr. Brendan Pang, a consultant pathologist and medical director.
Making Your Research Translatable: The Example of RENACER
Explore translational research strategies through RENACER example, enhancing impact of scientific discoveries in clinical settings.
The Role of TRAIL in Premetastatic Niche Formation in Breast Cancer
Explore groundbreaking research on TRAIL's role in breast cancer metastasis, uncovering its function as a vascular gatekeeper and its therapeutic potential in preventing premetastatic niche formation.
Translating Human Readable Variation Descriptions to Unique Computable Variations with the Variation Normalizer
Learn to translate human-readable genetic variation descriptions into unique computable variations using the Variation Normalizer tool for improved cancer genomics analysis and diagnosis.
Two Co-occurring Driver Mutations in Primary Lung Adenocarcinoma - Who's Driving Treatment?
Explore co-occurring driver mutations in lung adenocarcinoma, their impact on RAS signaling, and implications for targeted therapies. Gain insights into clinical cases and treatment strategies.